| Tag | Content |
|---|
EnhancerAtlas ID | HS073-13897 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr8:56847140-56848170 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Zfx | MA0146.2 | chr8:56848092-56848106 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10228 | chr8:56846730-56848227 | CD19_Primary | | SE_10861 | chr8:56823723-56864289 | CD20 | | SE_53331 | chr8:56846088-56848132 | Spleen | | SE_58404 | chr8:56735034-56858189 | Ly1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I055934 | chr8 | 56847172 | 56847919 |
|
Enhancer Sequence | GACAGGCAGA ATGAGGGGAG CCCTGGGACA GCATCTGGCT GTTTTGTCTT GACACCCCTT 60
TCCTCAGTGC TCAACCCTGC ATGAGACATG AAGAGAAGAG AAGAGCCAAC TCCTTATTCA 120
GACCCAGAGA CATCCCTCCT GTGTTGAGGG GGGTGCACCC TGTAACTAGC TAGCTAGTCT 180
TAAACCCACT TCCCACCTCA CCCCCCTTTC CCAATTGACC CTCAATAGTC AAAGTGAATG 240
GAGGCTGGCA GGCACCTTGG ACACAGGTTC TATCCCAGTC TTTACTCTTT CCAACACTCC 300
TTCAGACACC TCTTTCTCAC TTCTCCTAAA TCATATCCTC CTCCCTTCTA GGGGGAGCCT 360
GATGGCTCAC CTTAGTCACA GACAGGAGCT GACACCTAAC CATCGAAGCA GCTCTGTGGT 420
GGAGGTGATG CCCACACCAT GGACGGAAGC AGCTCCACGG GCCATGGTCA TAGCCTAGAG 480
GTGACGCCCA CACCATGGAG GCAGCTCTGT GATCTGAGGG ATTCCCGGCA CCGAAACAGC 540
ATTGCCTTAA TTGCCCCCAA ACACTGTTCC TATTACACAT GACATTTAAA CCTTAGGGAG 600
TTACATTCAT AATGTTAGGT TGCCTAAAGA AAAAAAACAA AAACAAAAGC AAACTGAAAA 660
AGCCTTAAGT AGGGCCTTAT GTTGCAGGCT GGTCAGATAG AGAAAGCCGT GCTATGCAGC 720
TTGGCCAGCC CGGGTTACCA GCTCACCAAC TGTGCCCACC CTGGCTGCTG GGAGATTTTA 780
TTGAGGAAAA ATATTGGAGA ATGTTTGAAA ATAATGACCA TGGTATGTAA GGCAAAAAAT 840
CTTAGTTGTT TAAATAAAGA CGGTCTGGCT AGGTCCTTTT CAGTTCTCTC TCTTTTAAAA 900
GTGATTTAGG TGCTGGGTGC AGTGGCTCAC GCCTGTAATC CCAGCACTTT GGGAGGCCGA 960
GGCGGGTGTA TCACCTGAGA TCAGGAGTTG GAGACCAGCC TGGCCAACAT GGTGAAACCC 1020
TGTCTGTACT 1030
|
